EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment.
about
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironmentTIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cellsA simple knowledge-based mining method for exploring hidden key molecules in a human biomolecular network.Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway.Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population.Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas.Anti-EGFR function of EFEMP1 in glioma cells and patient prognosis.Overexpression of EFEMP1 correlates with tumor progression and poor prognosis in human ovarian carcinomaTumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneityFibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomasMitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes.EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway.Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.Cell context-dependent dual effects of EFEMP1 stabilizes subpopulation equilibrium in responding to changes of in vivo growth environmentEpidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics.Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited macular degeneration.Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling.EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway.Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population.The associations between common SNPs of EFEMP1 gene and glioma risk in Chinese population.Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models.Deconvolution of Human Brain Cell Type Transcriptomes Unraveled Microglia-Specific Potential Biomarkers.
P2860
Q24628879-A1D9D835-9B40-4506-BF5A-C44AE3C87A3FQ26865615-B31C8365-CA09-4849-9DF5-20554DDC4F27Q28385210-3488F40F-FD86-4231-83B6-97835825E47DQ31090650-447F4BC6-0FBE-4190-9D58-C1344C104127Q33598331-ABD25925-E24D-4FA8-B0FE-B7900C811807Q33914032-A8B32ADE-5854-4DFC-B983-457661708F16Q34287855-999CE287-4349-4E9F-A101-E5668A7B94D7Q34781171-6E8AEB22-C948-485C-8D68-47763E0DDB88Q35043581-7DA256A5-25DF-4B21-94F2-C6D016863486Q35055173-F14C8A09-8C6B-48E7-A8C4-98A9DD13610CQ35177014-3FCB95F2-24B9-4C9A-9312-02B6F07D305FQ35882554-3D7EFA65-39BF-46C0-AD4A-8BCFCF614195Q35987298-56292182-6572-41B1-9612-B5984C15303FQ36081391-CCD37BA9-9F71-4646-AD68-0C4573E8DD2CQ36544417-7F097A66-6E4F-4603-90DA-B0CBAA10E774Q36794310-DC1BE388-6507-4E34-B11C-27034FC40C93Q37064102-C1AEB652-3ABF-44C0-BB66-BDF088D30E39Q37298184-52485C4C-254E-4162-B7A1-880067A7E2E8Q37380159-D5ED6FD1-F99A-43F7-BB14-5B5BFA44BE6BQ37494827-8B99AA02-5FA4-4567-8AC8-13F4F192FFDBQ37565332-DEB5B0C7-8C74-4CB3-9349-00EDA38DF796Q37745906-3ED5A22A-D2B2-4146-AB90-9702E0EB6850Q38637324-7238F79E-B9B9-486A-B577-4A436A144C95Q39098768-853FF2D8-DCB0-48B5-9D30-92932DA01120Q45824718-48D5D829-1052-4A56-A7CD-410C67D8EB17Q46582256-085652FA-239D-4215-87D7-3A53E20E0E60Q47128907-E0AB59D9-5771-4DFC-8FA6-8339783C18B3Q54979169-95807257-32DB-4BD4-9BC4-547ED4E0D958
P2860
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
EFEMP1 suppresses malignant gl ...... mor extracellular compartment.
@ast
EFEMP1 suppresses malignant gl ...... mor extracellular compartment.
@en
type
label
EFEMP1 suppresses malignant gl ...... mor extracellular compartment.
@ast
EFEMP1 suppresses malignant gl ...... mor extracellular compartment.
@en
prefLabel
EFEMP1 suppresses malignant gl ...... mor extracellular compartment.
@ast
EFEMP1 suppresses malignant gl ...... mor extracellular compartment.
@en
P2093
P2860
P356
P1433
P1476
EFEMP1 suppresses malignant gl ...... mor extracellular compartment.
@en
P2093
Abhishek Chaturbedi
Daniel I Ro
Eric Siegel
Jodi Nelson
Kenneth R Hess
Mark E Linskey
Mark Hamamura
Marlon S Mathews
Nelson Hsu
P2860
P2888
P356
10.1186/1476-4598-10-123
P577
2011-09-28T00:00:00Z
P5875
P6179
1002274143